Rhythm Biosciences
(ASX) RHY
Rhythm Biosciences Financials at a Glance
Market Cap
$63.65M
Revenue (TTM)
$5.66M
Net Income (TTM)
$8.85M
EPS (TTM)
$-0.02
P/E Ratio
-8.39
Dividend
$0.00
Beta (Volatility)
-0.08 (Low)
Dividend
$0.00
Beta (Volatility)
-0.08 (Low)
Price
$0.19
Volume
1,450,450
Open
$0.18
Price
$0.19
Volume
1,450,450
Open
$0.18
Previous Close
$0.19
Daily Range
$0.17 - $0.20
52-Week Range
$0.05 - $0.28
Dividend
$0.00
Beta (Volatility)
-0.08 (Low)
Price
$0.19
Volume
1,450,450
Open
$0.18
Previous Close
$0.19
Daily Range
$0.17 - $0.20
52-Week Range
$0.05 - $0.28
RHY News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Rhythm Biosciences
Industry
Healthcare Providers and Services
Sector
Health CareCEO
David George Atkins, PhD, MBA
Website
www.rhythmbio.comHeadquarters
Parkville, VIC 3010, AU
RHY Financials
Key Financial Metrics (TTM)
Gross Margin
-64%
Operating Margin
-112%
Net Income Margin
-94%
Return on Equity
-190%
Return on Capital
-4%
Return on Assets
-2%
Earnings Yield
-11.92%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$63.65M
Shares Outstanding
340.37M
Volume
1.45M
Short Interest
0.00%
Avg. Volume
953.74K
Financials (TTM)
Gross Profit
$2.97M
Operating Income
$3.53M
EBITDA
$3.53M
Operating Cash Flow
$2.92M
Capital Expenditure
$23.21K
Free Cash Flow
$2.94M
Cash & ST Invst.
$1.48M
Total Debt
$1.11M
Rhythm Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$46.25K
-97.3%
Gross Profit
$2.14M
+16.7%
Gross Margin
-46.24%
N/A
Market Cap
$63.65M
N/A
Market Cap/Employee
$2.77M
N/A
Employees
23
N/A
Net Income
$2.26M
+44.8%
EBITDA
$3.69M
+34.9%
Quarterly Fundamentals
Net Cash
$1.47M
+19.8%
Accounts Receivable
$61.39K
-19.8%
Inventory
$73.29K
+1687.7%
Long Term Debt
$0.00
N/A
Short Term Debt
$262.44K
+237.0%
Return on Assets
-2.15%
N/A
Return on Invested Capital
-3.70%
N/A
Free Cash Flow
$2.22M
+29.0%
Operating Cash Flow
$2.22M
+27.1%